Feature
“It’s been devastating”: How COVID-19 is impacting Alzheimer’s research and care
Alzheimer’s researcher Dr Ashwin Venkataraman shares first-hand insights into how the COVID-19 pandemic has affected patients and ongoing research.
Vaping study and COVID exit strategy: News from the College
Here’s a batch of fresh news and announcements from across Imperial.
AI-based brain monitoring and robotic muscle projects win £11.5m EPSRC boost
Two Imperial College London projects have won a total of £11.5 million to transform healthcare technologies by 2050.
Studying coronavirus transmission in children could help cut COVID spread
Imperial researchers are set to begin a study exploring how the virus causing COVID-19 is transmitted by children.
Many nations falling behind on global efforts to cut chronic disease deaths
Many countries are falling behind on global commitments to cut premature deaths from chronic diseases such as diabetes, lung cancer and heart disease.
Video
Hip fracture risk linked to nanoscale bone inflexibility
New research has highlighted a preventative treatment gap in patients prone to bone fractures who are otherwise healthy.
Feature
T cell immunity: What is it and how does it help to protect us from COVID-19?
Over the past few months, you’ll have heard a lot about the importance of antibodies and how they can help us to understand our immunity to COVID-19.
1
Imperial and The George Institute to drive sustainable global health systems
Imperial has established a new partnership with The George Institute for Global Health, focusing on innovative and sustainable global health systems.
Raised iron levels linked to reduced life expectancy
Having too much iron in the body puts your long term health at risk but it could also take years off your life.
Imperial White City Incubator companies pivot in response to COVID-19
Companies at Imperial’s startup incubator are adapting their technology and applying their skillsets to help the fight against the pandemic.
